RESÚMENES AGOSTO 2005

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Longitudinal comparison of depressive personality disorder and dysthymic disorder

John C. Markowitz, Andrew E. Skodol, Eva Petkova, Hui Xie, Jianfeng Cheng, David J. Hellerstein, John G. Gunderson, Charles A. Sanislow, Carlos M. Grilo, Thomas H. McGlashan

Comprenhensive Psychiatry. Volume 46, Issue 4, Pages 239-245 (July 2005)

 

Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression

Benjamin F. Rodriguez, Steven E. Bruce, Maria E. Pagano and Martin B. Keller

Journal of Anxiety Disorders. Volume 19, Issue 7, 2005, Pages 752-766

 

NAG level differences in panic disorder and agoraphobia

Michael J. Garvey and Russell Noyes, Jr.

Journal of Anxiety Disorders. Volume 19, Issue 7, 2005, Pages 818-825

 

Suicide Risk in Patients Treated With Lithium

Lars Vedel Kessing, Lars Søndergård, Kajsa Kvist, Per Kragh Andersen

Arch Gen Psychiatry. 2005;62:860-866

 

Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients

Carlos A. de Mendonça Lima, Pierre Baumann, Marlyse Brawand-Amey, Christian Brogli, Sylvie Jacquet, Nathalie Cochard, Kerry Powell-Golay and Chin B. Eap

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 29, Issue 6, July 2005, Pages 952-956

 

Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene
Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, Czerski PM, Hauser J

Pharmacopsychiatry. 2005 Jul;38(4):166-70

 

An Open Study of Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder

Dan V. Iosifescu, Andrew A. Nierenberg, David Mischoulon, Roy H. Perlis, George I. Papakostas, Julie L. Ryan, Jonathan E. Alpert, and Maurizio Fava

J Clin Psychiatry 2005;66:1038-1042

 

Predictors of Remission After Electroconvulsive Therapy in Unipolar Major Depression

Alexandre Y. Dombrovski, Benoit H. Mulsant, Roger F. Haskett, Joan Prudic, Amy E. Begley, and Harold A. Sackeim

J Clin Psychiatry 2005;66:1043-1049

 

Symptom Clusters as Predictors of Late Response to Antidepressant Treatment

Madhukar H. Trivedi, David W. Morris, Bruce D. Grannemann, and Susan Mahadi

J Clin Psychiatry 2005;66:1064-1070

 

Association Between Pain and Depression Among Older Adults in Europe: Results From the Aged in Home Care (AdHOC) Project: A Cross-Sectional Study

Graziano Onder, Francesco Landi, Giovanni Gambassi, Rosa Liperoti, Manuel Soldato, Chiara Catananti, Harriet Finne-Soveri, Cornelius Katona, Iain Carpenter, and Roberto Bernabei

J Clin Psychiatry 2005;66:982-988

 

Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials

Michael E. Thase, Barbara R. Haight, Nathalie Richard, Carol B. Rockett, Melinda Mitton, Jack G. Modell, Susan VanMeter, April E. Harriett, and Younghua Wang

J Clin Psychiatry 2005;66:974-981

 

Antidepressant Exposure May Protect Against Decrement in Frontal Gray Matter Volumes in Geriatric Depression

Helen Lavretsky, Donna J. Roybal, Martina Ballmaier, Arthur W. Toga, and Anand Kumar

J Clin Psychiatry 2005;66:964-967

 

Effectiveness of treatments for depression in older people
Frazer CJ, Christensen H, Griffiths KM

Med J Aust. 2005 Jun 20;182(12):627-32

 

Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study
Amsterdam, Jay D.; Shults, Justine

International Clinical Psychopharmacology. 20(5):257-264, September 2005

A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan
Kamijima, Kunitoshi; Kuboki, Tomifusa; Kumano, Hiroaki; Burt, Tal; Cohen, Guy; Arano, Ichiro; Hamasaki, Toshimitsu

International Clinical Psychopharmacology. 20(5):265-273, September 2005

Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach

Astrid Zobel, Alexius Joe, Nikolaus Freymann, Hans Clusmann, Johannes Schramm, Michael Reinhardt, Hans-Jürgen Biersack, Wolfgang Maier and Karl Broich

Psychiatry Research: Neuroimaging. Volume 139, Issue 3, 30 August 2005, Pages 165-179

 

Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study
Baldomero EB, Ubago JG, Cercos CL, Ruiloba JV, Calvo CG, Lopez RP

Depress Anxiety. 2005 Aug 10; [Epub ahead of print]

 

Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression
Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN

Depress Anxiety. 2005 Aug 10; [Epub ahead of print]

 

Maternal valproate dosage and foetal malformations

Vajda FJE, Eadie MJ

Acta Neurol Scand 2005: 112: 137-143

 

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder
Steiner M, Hirschberg AL, Bergeron R, Holland F, Gee MD, Van Erp E

Am J Obstet Gynecol. 2005 Aug;193(2):352-60

 

Association Study of a Monoamine Oxidase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response
Younger W-Y Yu, Shih-Jen Tsai, Chen-Jee Hong, Tai-Jui Chen, Ming-Chao Chen and Chih-Wei Yang

Neuropsychopharmacology (2005) 30, 1719-1723

Risk factors associated with the development of postpartum mood disorders

Miki Bloch, Nivi Rotenberg, Dan Koren and Ehud Klein

Journal of Affective Disorders. Volume 88, Issue 1, September 2005, Pages 9-18

 

A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia

Kristin Mitte

Journal of Affective Disorders. Volume 88, Issue 1, September 2005, Pages 27-45

 

Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder

Okan Caliyurt and Funda Guducu

Journal of Affective Disorders. Volume 88, Issue 1, September 2005, Pages 75-78

 

Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: A meta-analysis

Noriyuki Kitayama, Viola Vaccarino, Michael Kutner, Paul Weiss and J. Douglas Bremner

Journal of Affective Disorders. Volume 88, Issue 1, September 2005, Pages 79-86

 

Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder?

Steven D. Barger and Sumner J. Sydeman

Journal of Affective Disorders. Volume 88, Issue 1, September 2005, Pages 87-91

 

Temporal stability of symptom dimensions in adult patients with obsessive–compulsive disorder

Michael Rufer, Andreas Grothusen, Reinhard Maß, Helmut Peter and Iver Hand

Journal of Affective Disorders. Volume 88, Issue 1, September 2005, Pages 99-102

 

Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study
Saiz-Ruiz J, Montes JM, Ibanez A, Diaz M, Vicente F, Pelegrin C, Vinas R, Arias F, Carrasco JL, Ferrando L

Hum Psychopharmacol. 2005 Aug 17;20(6):435-440 [Epub ahead of print]

 

A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder
Kasper S, Olivieri L, Di Loreto G, Dionisio P

Curr Med Res Opin. 2005 Aug;21(8):1139-46

 

 

Relationship of anger and anger attacks with depression. A brief review

N. Painuly, P. Sharan and S. K. Mattoo

European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 4: 215 - 222

 

Suicide in severe depression related to treatment. Depressive characteristics and rate of antidepressant overdose

L. Brådvik and M. Berglund 

European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 4: 245 - 250

 

 

Placebo–controlled trials in major depression are necessary and ethically justifiable. How to improve the communication between researchers and ethical committees

D. Adam, S. Kasper, H.-J. Möller and E. A. Singer

European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 4: 258 - 260

 

 

Review Toward Convergence in the Medication Treatment of Bipolar Disorder and Schizophrenia
Leslie Citrome, Joseph F. Goldberg, Stephen M. Stahl

Harvard Review of Psychiatry. Volume 13, Number 1 / January-February 2005: 28 - 42

 

The experience of bipolar disorder: a personal perspective on the impact of mood disorder symptoms

J Licinio

Molecular Psychiatry (2005) 10, 827−830

 

Depression during pregnancy
Ryan D, Milis L, Misri N

Can Fam Physician. 2005 Aug;51:1087-93

.

Regresar a RESÚMENES AGOSTO 2005